Gyeonggi-do
South Korea
9
2023-05-11
9
2025-09-09
These are the the leading inventors for applications assigned to QURIENT, CO. LTD.:
QURIENT, CO. LTD. based in Gyeonggi-do, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
DIFFERENT FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE
#2 | 2022-12-08 ✅ Patent 12,582,598 granted on 2026-03-24A TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING ZILEUTON
#3 | 2022-03-31 ✅ Patent 12,606,561 granted on 2026-04-21PHARMACEUTICALLY ACTIVE PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES
#4 | 2021-06-03 ✅ Patent 12,162,858 granted on 2024-12-10Quinoline derivatives as inhibitors of AXL/MER RTK and CSF1R
#5 | 2021-05-20 ✅ Patent 11,945,822 granted on 2024-04-02Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase
#6 | 2021-05-13 ✅ Patent 11,858,937 granted on 2024-01-02Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors
#7 | 2018-04-05 ✅ Patent 10,934,274 granted on 2021-03-02Quinoline derivatives as TAM RTK inhibitors
#8 | 2017-06-15 ✅ Patent 11,447,486 granted on 2022-09-202-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors
#9 | 2014-06-05 ✅ Patent 9,029,389 granted on 2015-05-12Anti-inflammation compounds
Also check out QURIENT CO., LTD.'s (Gyeonggi-Do, South Korea) applicant profile with 14 patent applications submitted.
67130 ⎘